Nexam Chemical Holding AB (publ)
SSE:NEXAM.ST
2.91 (SEK) • At close February 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 190.277 | 221.756 | 219.452 | 165.83 | 130.057 | 109.835 | 18.694 | 8.268 | 7.842 | 1.602 | 2.547 | 0.764 |
| Cost of Revenue
| 211.183 | 135.024 | 134.972 | 94.88 | 78.376 | 65.146 | 10.453 | 4.442 | 4.329 | 1.911 | 3.02 | 1.229 |
| Gross Profit
| -20.906 | 86.732 | 84.48 | 70.95 | 51.681 | 44.689 | 8.241 | 3.826 | 3.513 | -0.309 | -0.473 | -0.465 |
| Gross Profit Ratio
| -0.11 | 0.391 | 0.385 | 0.428 | 0.397 | 0.407 | 0.441 | 0.463 | 0.448 | -0.193 | -0.186 | -0.609 |
| Reseach & Development Expenses
| 0 | 1.028 | 0.517 | 0.258 | 0.493 | 0.645 | 5.7 | 4.052 | 0 | 15.173 | 13.952 | 9.979 |
| General & Administrative Expenses
| 0 | 0 | 41.62 | 34.157 | 28.75 | 24.339 | 12.132 | 9.191 | 12.296 | 18.076 | 13.734 | 9.216 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 88.096 | 87.465 | 41.62 | 34.157 | 28.75 | 24.339 | 12.132 | 9.191 | 12.296 | 18.076 | 13.734 | 9.216 |
| Other Expenses
| 102.443 | 99.236 | 47.425 | 40.389 | 40.2 | 37.407 | 18.732 | 16.852 | 15.026 | 17.112 | 12.583 | 7.966 |
| Operating Expenses
| 102.443 | 99.236 | 89.045 | 74.546 | 68.95 | 61.746 | 30.864 | 26.043 | 27.322 | 35.188 | 26.317 | 17.182 |
| Operating Income
| -20.906 | -11.729 | -4.285 | -5.127 | -17.269 | -15.684 | -22.922 | -21.923 | -23.809 | -35.497 | -26.79 | -17.647 |
| Operating Income Ratio
| -0.11 | -0.053 | -0.02 | -0.031 | -0.133 | -0.143 | -1.226 | -2.652 | -3.036 | -22.158 | -10.518 | -23.099 |
| Total Other Income Expenses Net
| -1.107 | -0.956 | -1.023 | -2.466 | 0.25 | 0.03 | -0.41 | 0.132 | 0.1 | 0.444 | 0.282 | 0.043 |
| Income Before Tax
| -22.013 | -12.685 | -5.308 | -7.593 | -17.019 | -17.027 | -23.033 | -22.085 | -23.709 | -35.053 | -26.508 | -17.604 |
| Income Before Tax Ratio
| -0.116 | -0.057 | -0.024 | -0.046 | -0.131 | -0.155 | -1.232 | -2.671 | -3.023 | -21.881 | -10.408 | -23.042 |
| Income Tax Expense
| 0.83 | 0.02 | 0.157 | 0.496 | 0.054 | 0.153 | -17.285 | 0.369 | 0.333 | -0.001 | 0.005 | 0.208 |
| Net Income
| -22.843 | -12.705 | -5.465 | -8.089 | -17.073 | -17.18 | -5.748 | -22.085 | -23.709 | -35.052 | -26.513 | -17.604 |
| Net Income Ratio
| -0.12 | -0.057 | -0.025 | -0.049 | -0.131 | -0.156 | -0.307 | -2.671 | -3.023 | -21.88 | -10.41 | -23.042 |
| EPS
| -0.28 | -0.16 | -0.069 | -0.11 | -0.25 | -0.25 | -0.09 | -0.36 | -0.46 | -0.69 | -0.56 | -90.75 |
| EPS Diluted
| -0.28 | -0.16 | -0.069 | -0.11 | -0.25 | -0.25 | -0.089 | -0.36 | -0.45 | -0.68 | -0.56 | -90.75 |
| EBITDA
| -6.304 | 0.279 | 6.288 | 5.066 | -5.594 | -6.093 | -19.823 | -19.41 | -20.969 | -30.627 | -23.699 | -15.558 |
| EBITDA Ratio
| -0.033 | 0.001 | 0.029 | 0.031 | -0.043 | -0.055 | -1.06 | -2.348 | -2.674 | -19.118 | -9.305 | -20.364 |